标题
Molecular testing in malignant melanoma
作者
关键词
-
出版物
DIAGNOSTIC CYTOPATHOLOGY
Volume 40, Issue 6, Pages 503-510
出版商
Wiley
发表日期
2012-05-22
DOI
10.1002/dc.22810
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phase I/II study of GSK2118436, a selective inhibitor of oncogenic mutant BRAF kinase, in patients with metastatic melanoma and other solid tumors.
- (2017) R. Kefford et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of the c-Met Proteins in Malignant Skin Cancers
- (2011) Yoon-Jin Lee et al. Annals of Dermatology
- Combinatorial Treatments That Overcome PDGFR -Driven Resistance of Melanoma Cells to V600EB-RAF Inhibition
- (2011) H. Shi et al. CANCER RESEARCH
- Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
- (2011) Nikhil Wagle et al. JOURNAL OF CLINICAL ONCOLOGY
- Cutaneous melanoma: A model to study cancer metastasis
- (2011) Stanley P.L. Leong et al. JOURNAL OF SURGICAL ONCOLOGY
- KIT mutations in ocular melanoma: frequency and anatomic distribution
- (2011) Michelle L Wallander et al. MODERN PATHOLOGY
- BRAF targeted therapy changes the treatment paradigm in melanoma
- (2011) Antoni Ribas et al. Nature Reviews Clinical Oncology
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting KIT in melanoma: A paradigm of molecular medicine and targeted therapeutics
- (2010) Scott E. Woodman et al. BIOCHEMICAL PHARMACOLOGY
- Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy
- (2010) K H T Paraiso et al. BRITISH JOURNAL OF CANCER
- Clinical responses observed with imatinib or sorafenib in melanoma patients expressing mutations in KIT
- (2010) D Handolias et al. BRITISH JOURNAL OF CANCER
- Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K
- (2010) Jessie Villanueva et al. CANCER CELL
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
- (2010) Sonja J. Heidorn et al. CELL
- The PI3K Pathway As Drug Target in Human Cancer
- (2010) Kevin D. Courtney et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetic aberrations in primary esophageal melanomas: molecular analysis of c-KIT, PDGFR, KRAS, NRAS and BRAF in a series of 10 cases
- (2010) Rupert Langer et al. MODERN PATHOLOGY
- RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
- (2010) Poulikos I. Poulikakos et al. NATURE
- COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
- (2010) Cory M. Johannessen et al. NATURE
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Melanoma from bench to bedside: meeting report from the 6th international melanoma congress
- (2010) D. E. Fisher et al. Pigment Cell & Melanoma Research
- PLX4032, a selective BRAFV600E kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAFWT melanoma cells
- (2010) Ruth Halaban et al. Pigment Cell & Melanoma Research
- PAX3 and SOX10 activate MET receptor expression in melanoma
- (2010) Joseph B. Mascarenhas et al. Pigment Cell & Melanoma Research
- Targeted Therapy for Melanoma: A Primer
- (2010) Michael A. Davies et al. Surgical Oncology Clinics of North America
- Anal Mucosal Melanoma withKIT-Activating Mutation and Response to Imatinib Therapy – Case Report and Review of the Literature
- (2009) Imke Satzger et al. DERMATOLOGY
- Response to Imatinib Mesylate Depends on the Presence of the V559A-Mutated KIT Oncogene
- (2009) Patrick Terheyden et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type
- (2009) Carlos A Torres-Cabala et al. MODERN PATHOLOGY
- A comprehensive catalogue of somatic mutations from a human cancer genome
- (2009) Erin D. Pleasance et al. NATURE
- Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4
- (2009) Todd D Prickett et al. NATURE GENETICS
- Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas
- (2008) I Satzger et al. BRITISH JOURNAL OF CANCER
- A novel AKT3 mutation in melanoma tumours and cell lines
- (2008) M A Davies et al. BRITISH JOURNAL OF CANCER
- Elevated CRAF as a Potential Mechanism of Acquired Resistance to BRAF Inhibition in Melanoma
- (2008) C. Montagut et al. CANCER RESEARCH
- KIT Gene Mutations and Copy Number in Melanoma Subtypes
- (2008) C. Beadling et al. CLINICAL CANCER RESEARCH
- Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas
- (2008) Atsuko Ashida et al. INTERNATIONAL JOURNAL OF CANCER
- Major Response to Imatinib Mesylate in KIT-Mutated Melanoma
- (2008) F. Stephen Hodi et al. JOURNAL OF CLINICAL ONCOLOGY
- Frequencies of NRAS and BRAF Mutations Increase from the Radial to the Vertical Growth Phase in Cutaneous Melanoma
- (2008) Victoria R. Greene et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Dose-dependent, complete response to imatinib of a metastatic mucosal melanoma with a K642E KIT mutation
- (2008) Jose Lutzky et al. Pigment Cell & Melanoma Research
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search